About a dozen published studies have examined muscle function in dysf-/- mice, however these have yielded inconsistent and contrasting results, and often do not replicate the characteristic muscle weakness of human patients with dysferlinopathy (see Table 1). Here, DYSF is linked to neuromuscular disease caused by qualitative or quantitative defects of dysferlin.